It announced that it will sell its underperforming US weight management brand SlimFast, reported a 6.8 per cent increase in full-year adjusted earnings per share, and increased total dividends by 10 per cent.  Yet, it was the price of whey, a key raw material for its suite of protein products, that rattled investors in Irish food group Glanbia, driving down the company’s share price by up to 18 per cent following the publication of its 2024 results and the issuance of the group’s 2025 outlook.  The company confirmed a $200 million (€190 million) whey cost headwind for 2025, something that…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €50.

Subscribe

Cancel at any time.

Are you already a member? .